Evidence map›Paper›PMID 35230551›Full record

ArticleActa neurochirurgica2022

Assessment of neuropsychological function in brain tumor treatment: a comparison of traditional neuropsychological assessment with app-based cognitive screening.

Rafael Romero-Garcia, Mallory Owen, Alexa McDonald, Emma Woodberry, Moataz Assem, Pedro Coelho, Rob C Morris, Stephen J Price, Tom Santarius, John Suckling and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Precision Surgery for Glioblastomas.Journal of personalized medicine · 2025
    Review
  4. Review
  5. Tumour-infiltrated cortex participates in large-scale cognitive circuits.Cortex; a journal devoted to the study of the nervous system and behavior · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Rafael Romero-Garcia *Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Robinson Way, Cambridge, CB2 0SZ, UK. rr480@cam.ac.uk.ORCID 0000-0002-5199-4573
Mallory Owen *Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Robinson Way, Cambridge, CB2 0SZ, UK.
Alexa McDonaldDepartment of Neuropsychology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Emma WoodberryDepartment of Neuropsychology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Moataz AssemMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Pedro CoelhoNeurophys Limited, Cambridge, UK.
Rob C MorrisDepartment of Neurosurgery, Addenbrooke's Hospital, Cambridge, UK.
Stephen J PriceDepartment of Neurosurgery, Addenbrooke's Hospital, Cambridge, UK.
Tom SantariusDepartment of Neurosurgery, Addenbrooke's Hospital, Cambridge, UK.
John SucklingDepartment of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Robinson Way, Cambridge, CB2 0SZ, UK.
Tom ManlyCambridge and Peterborough NHS Foundation Trust, Cambridgeshire, UK.
Yaara ErezMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Michael G HartDepartment of Psychiatry, University of Cambridge, Herchel Smith Building for Brain and Mind Sciences, Robinson Way, Cambridge, CB2 0SZ, UK.
University of Cambridge · GBAddenbrooke's Hospital · GBCambridge University Hospitals NHS Foundation Trust · GBBar-Ilan University · ILCambridgeshire and Peterborough NHS Foundation Trust · GBMRC Cognition and Brain Sciences Unit · GB

Funding

Cancer Research UK A25117Cancer Research UK RG86786Medical Research Council MC_U105559837Medical Research Council MC_UU_00005/10Medical Research Council MC_UU_00005/6Medical Research Council MC_UU_00030/11Medical Research Council MC_UU_00030/7
6 · The paper itself

Abstract

backgroundGliomas are typically considered to cause relatively few neurological impairments. However, cognitive difficulties can arise, for example during treatment, with potential detrimental effects on quality of life. Accurate, reproducible, and accessible cognitive assessment is therefore vital in understanding the effects of both tumor and treatments. Our aim is to compare traditional neuropsychological assessment with an app-based cognitive screening tool in patients with glioma before and after surgical resection. Our hypotheses were that cognitive impairments would be apparent, even in a young and high functioning cohort, and that app-based cognitive screening would complement traditional neuropsychological assessment.

methodsSeventeen patients with diffuse gliomas completed a traditional neuropsychological assessment and an app-based touchscreen tablet assessment pre- and post-operatively. The app assessment was also conducted at 3- and 12-month follow-up. Impairment rates, mean performance, and pre- and post-operative changes were compared using standardized Z-scores.

resultsApproximately 2-3 h of traditional assessment indicated an average of 2.88 cognitive impairments per patient, while the 30-min screen indicated 1.18. As might be expected, traditional assessment using multiple items across the difficulty range proved more sensitive than brief screening measures in areas such as memory and attention. However, the capacity of the screening app to capture reaction times enhanced its sensitivity, relative to traditional assessment, in the area of non-verbal function. Where there was overlap between the two assessments, for example digit span tasks, the results were broadly equivalent.

conclusionsCognitive impairments were common in this sample and app-based screening complemented traditional neuropsychological assessment. Implications for clinical assessment and follow-up are discussed.

Indexed as

Brain NeoplasmsCognition DisordersGliomaMobile ApplicationsCognitionHumansNeuropsychological TestsQuality of LifeCognitive functionGliomaNeuropsychiatryNeuropsychologyNeurosurgery

Identifiers

PMID35230551
PMCPMC9338148
OpenAlexW4214639465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.